chr2-73780051-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001424649.1(DUSP11):c.65C>T(p.Ser22Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000558 in 1,612,000 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001424649.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DUSP11 | NM_003584.3 | c.-77C>T | 5_prime_UTR_variant | 1/9 | ENST00000272444.8 | NP_003575.3 | ||
DUSP11 | NM_001424649.1 | c.65C>T | p.Ser22Phe | missense_variant | 1/9 | NP_001411578.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DUSP11 | ENST00000272444.8 | c.-77C>T | 5_prime_UTR_variant | 1/9 | 1 | NM_003584.3 | ENSP00000272444.4 |
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152234Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000124 AC: 3AN: 241790Hom.: 0 AF XY: 0.00000762 AC XY: 1AN XY: 131308
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1459648Hom.: 0 Cov.: 36 AF XY: 0.00000275 AC XY: 2AN XY: 726016
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152352Hom.: 0 Cov.: 34 AF XY: 0.0000403 AC XY: 3AN XY: 74504
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 07, 2024 | The c.65C>T (p.S22F) alteration is located in exon 1 (coding exon 1) of the DUSP11 gene. This alteration results from a C to T substitution at nucleotide position 65, causing the serine (S) at amino acid position 22 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at